Postmenopausal estrogen and the risk of breast cancer. The need for randomized trials

Ann Epidemiol. 1994 May;4(3):255-6. doi: 10.1016/1047-2797(94)90105-8.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Aged
  • Breast Neoplasms / chemically induced*
  • Dose-Response Relationship, Drug
  • Estrogen Replacement Therapy / adverse effects*
  • Estrogens, Conjugated (USP) / administration & dosage
  • Estrogens, Conjugated (USP) / adverse effects*
  • Female
  • Humans
  • Long-Term Care
  • Middle Aged
  • Osteoporosis, Postmenopausal / drug therapy*
  • Risk Factors

Substances

  • Estrogens, Conjugated (USP)